Table 4 The adverse events of patients during follow-up.

From: A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer

Follow-up

 

IRE group

Relationship with the procedure

3 months

AE

7/383 (1.8%)

 

AE Grade

  

1

2

Not related/Probably

2

3

2 Probably/ Possibly

3

1

Definitely

4

1

Not related

6 months

AE

2/299 (0.67%)

 

AE Grade

  

1

1

Probably

2

1

Not related

9 months

AE

1/240 (0.42%)

 

AE Grade

  

1

1

Not related

12 months

AE

0/264

 

15 months

AE

1/175 (0.57%)

 

AE Grade

  

3

1

Not related

18 months

AE

0/155

 

21 months

AE

0/118

 

24 months

AE

1/158 (0.63%)

 
 

AE Grade

  
 

2

1

Definitely

30 months

AE

0/122

 

36 months

AE

1/99 (1.0%)

 
 

AE Grade

  
 

2

1

Not related

48 months

AE

0/48

 
  1. IAE adverse events.